Drug Shortage Report for JAMP DORZOLAMIDE-TIMOLOL
Report ID | 189263 |
Drug Identification Number | 02457539 |
Brand name | JAMP DORZOLAMIDE-TIMOLOL |
Common or Proper name | Dorzolamide and Timolol eye drops |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10 |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-04-11 |
Estimated end date | 2023-07-14 |
Actual end date | 2023-07-17 |
Shortage status | Resolved |
Updated date | 2023-07-18 |
Company comments | Increase in demand. Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-07-18 | English | Compare |
v9 | 2023-07-17 | French | Compare |
v8 | 2023-07-17 | English | Compare |
v7 | 2023-06-22 | French | Compare |
v6 | 2023-06-22 | English | Compare |
v5 | 2023-04-12 | English | Compare |
v4 | 2023-04-11 | French | Compare |
v3 | 2023-04-11 | English | Compare |
v2 | 2023-04-11 | French | Compare |
v1 | 2023-04-11 | English | Compare |
Showing 1 to 10 of 10